Positive Expression of E-cadherin Retards More Human Breast Carcinoma Cells in G0/G1 Phase and its Molecular Mechanism
DOI:
Author:
Affiliation:

Clc Number:

Fund Project:

This work was supported by grants from The National Natural Sciences Foundation of China (30000083) , Science and Technology Bureau of Shanghai Municipal Government (00JC 14042) and The Key Laboratory of Molecular Medicine, Ministry of Education, China.

  • Article
  • |
  • Figures
  • |
  • Metrics
  • |
  • Reference
  • |
  • Related
  • |
  • Cited by
  • |
  • Materials
  • |
  • Comments
    Abstract:

    E-cadherin-negative human breast carcinoma cell lines, MDA-MB-231 and MDA-MB-435 were transfected with wild-type E-cadherin cDNA. Flow cytometry showed that E-cadherin-positive transfectants grew slower than the control cells and more cells were relayed in G0/G1 phase. Western blot showed that it was due to down-regulation of protein concentration of cyclin D1 and β-catenin, the cyclin D1 gene transcriptional regulator. At the meantime, PKB protein level, which can inhibit β-catenin destruction through GSK-3β, was also down-regulated. As the PKB activators, FAK and ILK protein levels were decreased and PKB inhibitor, PTEN was increased by positive expression of E-cadherin. Therefore, E-cadherin can inhibit PKB activity by down-regulation of FAK, ILK and up-regulation of PTEN. As a result, β-catenin and cyclin D1 protein level increased and more cells were retarded in G0/G1 phase.

    Reference
    Related
    Cited by
Get Citation

WU Heng, SHEN Min-Xiong, LIANG Yu-Long, DUAN Ling-Ling, WANG Li-Ying, XU Zhen, ZHA Xi-Liang. Positive Expression of E-cadherin Retards More Human Breast Carcinoma Cells in G0/G1 Phase and its Molecular Mechanism[J]. Progress in Biochemistry and Biophysics,2003,30(3):435-441

Copy
Share
Article Metrics
  • Abstract:
  • PDF:
  • HTML:
  • Cited by:
History
  • Received:November 22,2002
  • Revised:December 28,2002
  • Accepted:
  • Online:
  • Published: